Life AI Net
Home
Archive
Calculators
Directory
Newsletter
Login
English
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Home
Archive
Calculators
Directory
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Login
Home
Archive
Calculators
Directory
More
Live
FierceBiotech
Ipsen unveils data for Botox rival that drove long-acting anti-wrinkle jab into phase 3
FierceBiotech
Analysts ‘shaking heads’ after Regeneron melanoma drug fails to beat Keytruda in phase 3 trial
BioPharma Dive
Unlocking more value from mature drug products through strategic outsourcing
GCC
GCC Hydroxypropyl Methylcellulose Market Report 2026–2034 | Construction and Pharma Trends - vocal.media
FierceBiotech
Ardent Health taps Fujifilm’s AI-enabled patient imaging platform
FierceBiotech
Executing biomarker-driven oncology trials
10x Genomics News
Assessing 10x Genomics (TXG) Valuation After Q1 2026 Results And Rising AI Trading Interest - simplywall.st
Lonza News
Lonza Group AG stock (CH0013841017): focus shifts to growth after strategic review and margin reset - AD HOC NEWS
eLife
Surging towards a better understanding of ovulation
Thermo Fisher
Thermo Fisher Scientific Inc. (TMO) Unveils Bioprocess Design Center to Develop Life-Changing Therapies - Yahoo Finance
Samsung Biologics
Korean Pharma, Biotech Firms Post Strong Q1 Sales While Profitability Diverges - thelec.net
FierceBiotech
Ipsen unveils data for Botox rival that drove long-acting anti-wrinkle jab into phase 3
FierceBiotech
Analysts ‘shaking heads’ after Regeneron melanoma drug fails to beat Keytruda in phase 3 trial
BioPharma Dive
Unlocking more value from mature drug products through strategic outsourcing
GCC
GCC Hydroxypropyl Methylcellulose Market Report 2026–2034 | Construction and Pharma Trends - vocal.media
FierceBiotech
Ardent Health taps Fujifilm’s AI-enabled patient imaging platform
FierceBiotech
Executing biomarker-driven oncology trials
10x Genomics News
Assessing 10x Genomics (TXG) Valuation After Q1 2026 Results And Rising AI Trading Interest - simplywall.st
Lonza News
Lonza Group AG stock (CH0013841017): focus shifts to growth after strategic review and margin reset - AD HOC NEWS
eLife
Surging towards a better understanding of ovulation
Thermo Fisher
Thermo Fisher Scientific Inc. (TMO) Unveils Bioprocess Design Center to Develop Life-Changing Therapies - Yahoo Finance
Samsung Biologics
Korean Pharma, Biotech Firms Post Strong Q1 Sales While Profitability Diverges - thelec.net
Archive
This story is not available in the archive.